Brimonidine gel 0.33% rapidly improves patient‐reported outcomes by controlling facial erythema of rosacea: a randomized, double‐blind, vehicle‐controlled study - Layton - 2015 - Journal of the European Academy of Dermatology and Venereology -
Mirvaso: topical treatment for erythema of rosacea